SVB Wealth’s Nautilus Biotechnolgy NAUT Stock Holding History

SVB Wealth’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,094	Closed	-$4.39K	–	1193
2025 Q1	$4.39K	Buy	+5,094	New	+$7.57K	﹤0.01%	1059

Other funds holding NAUT

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

SVB Wealth's NAUT Position: Q2 2025 in Review

SVB Wealth sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 5,094 shares — an estimated $4.39K sold.

SVB Wealth first reported a position in NAUT in Q1 2025 and held it in 1 quarter. The position peaked at $4.39K in Q1 2025. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

SVB Wealth reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 5,094 Nautilus Biotechnolgy shares in Q2 2025, an estimated $4.39K.
SVB Wealth first reported a position in Nautilus Biotechnolgy in Q1 2025 and held it in 1 quarter.
SVB Wealth's Nautilus Biotechnolgy position peaked at $4.39K in Q1 2025.
71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.